- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06899009
Ventilator Settings and Outcomes in Pediatric Patients on ECMO for Severe Respiratory Failure
Ventilator Settings and Outcomes in Pediatric Patients on ECMO for Severe Respiratory Failure - a Posthoc Analysis of the ELSO Registry
Study Overview
Status
Detailed Description
Rationale:
Despite the growing use of ECMO in critically ill pediatric patients, uncertainties remain to what extent adjustments of ventilator settings after ECMO initiation are associated with mortality.
Objectives:
- To describe the effects of ECMO initiation on the intensity of ventilation in the first 24 hours after ECMO initiation; and
- To explore associations between changes in ventilation intensity and hospital mortality in critically ill pediatric patients requiring ECMO for respiratory failure
Hypothesis:
- Ventilation intensity decreases following initiation of ECMO; and
- A decrease in ventilation intensity is associated with lower hospital mortality in critically ill pediatric patients.
Study design:
This is a posthoc analysis of the ELSO registry.
Study population:
For this analysis, data will be obtained from the ELSO registry. All pediatric patients (aged ≥29 days to ≤18 years) receiving ECMO for a pulmonary indication between January 1, 2012, and December 31, 2022 will be included. Patients with missing ventilatory variables required to assess ventilation intensity and patients lost to follow up with respect to hospital mortality will be excluded.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Groningen, Netherlands
- University Medical Center Groningen
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients (aged ≥29 days to ≤18 years) receiving ECMO between January 1, 2012, and December 31, 2022, in an ELSO affiliated center; and
- Requiring ECMO for a pulmonary indication.
Exclusion Criteria:
- Patients with missing ventilatory variables required to assess ventilation intensity;
- patients who were lost to follow up with respect to hospital mortality.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Children with respiratory failure on ECMO
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Hospital mortality
Time Frame: Up to 90 days of study or whatever comes first
|
Up to 90 days of study or whatever comes first
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Hospital length of stay
Time Frame: Up to 90 days of study or whatever comes first
|
Up to 90 days of study or whatever comes first
|
|
Duration of ECMO run
Time Frame: Up to 90 days of study or whatever comes first
|
Up to 90 days of study or whatever comes first
|
|
Duration of invasive ventilation
Time Frame: Up to 90 days of study or whatever comes first
|
Up to 90 days of study or whatever comes first
|
Collaborators and Investigators
Investigators
- Principal Investigator: Martin CJ Kneyber, MD PhD FCCM, University Medical Center Groningen
- Principal Investigator: Marcus J Schultz, MD PhD, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Principal Investigator: Frederique Paulus, RN PhD, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Ped.ECMO.1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Critical Illness
-
Duke UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...Not yet recruitingDecision Making | Neonatal Critical Illness | Pediatric Critical IllnessUnited States
-
Duke UniversityNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes...CompletedNeonatal Critical Illness | Pediatric Critical IllnessUnited States
-
Istituto Clinico HumanitasRecruitingCritical Illness Myopathy | Critical Illness Polyneuropathy | Critical Illness PolyneuromyopathyItaly
-
Assistance Publique - Hôpitaux de ParisEuropean Society of Intensive Care Medicine; French Society for Intensive Care and other collaboratorsRecruitingCritical Illness | Intensive Care Patients | Critical Illness Requiring Intensive Care - Sepsis | Critical Illness Requiring Intensive Care - Acute Brain Injury | Critical Illness Requiring Intensive Care - Major Surgery | Critical Illness Requiring Intensive Care - PolytraumaFrance
-
Boston Children's HospitalCompleted
-
Karolinska InstitutetNot yet recruitingPediatric Critical IllnessSweden
-
McMaster UniversityLondon Health Sciences Centre; McMaster Children's Hospital; Canadian Critical...CompletedPediatric Critical IllnessCanada
-
Sándor BeniczkyUniversity of Aarhus; Danish Council for Independent Research; Søster og Verner...CompletedCritical Illness Myopathy | Myopathy Critical IllnessDenmark
-
Istanbul Medeniyet UniversityRecruiting
-
University Hospital Birmingham NHS Foundation TrustCompletedRehabilitation After Critical Illness